In addition, GHR inhibition induced significant decrease of breast cancer cell growth by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐tetrazolium bromide assay (Fig. 2E,F). Here, GHR is linked to breast carcinoma.